Annotations: 1BR9

Domain Annotation: SCOP/SCOPe Classification SCOP Database Homepage

Chains	Domain Info	Class	Fold	Superfamily	Family	Domain	Species	Provenance Source (Version)
A	d1br9a_	All beta proteins	OB-fold	TIMP-like	Tissue inhibitor of metalloproteinases, TIMP	TIMP-2	human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)

Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

Chains	Type	Family Name	Domain Identifier	Family Identifier	Provenance Source (Version)
A	SCOP2 Family	Tissue inhibitor of metalloproteinases TIMP	8029528	4001872	SCOP2 (2022-06-29)
A	SCOP2 Superfamily	TIMP-like	8041907	3000488	SCOP2 (2022-06-29)

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	TIMP	e1br9A1	A: beta barrels	X: OB-fold	H: TIMP-like (From Topology)	T: TIMP-like	F: TIMP	ECOD (1.6)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
A	3.90.370.10	Alpha Beta	Alpha-Beta Complex	Tissue inhibitor of metalloproteinase-1. Chain B, domain 1	Tissue inhibitor of metalloproteinase-1. Chain B, domain 1	CATH (4.3.0)
A	2.40.50.120	Mainly Beta	Beta Barrel	OB fold (Dihydrolipoamide Acetyltransferase, E2P)		CATH (4.3.0)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A	PF00965	Tissue inhibitor of metalloproteinase (TIMP)	Tissue inhibitor of metalloproteinase	Members of this family are common in extracellular regions of vertebrate species	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	METALLOPROTEINASE-2 INHIBITOR	molecular function inhibitor activity molecular function regulator activity enzyme regulator activity peptidase regulator activity enzyme inhibitor activity peptidase inhibitor activity protein binding binding enzyme binding protease binding cation binding transition metal ion binding zinc ion binding ion binding molecular function inhibitor activity molecular function regulator activity enzyme regulator activity peptidase regulator activity enzyme inhibitor activity peptidase inhibitor activity protein binding binding enzyme binding protease binding cation binding transition metal ion binding zinc ion binding ion binding metal ion binding small molecule binding endopeptidase regulator activity metalloendopeptidase inhibitor activity endopeptidase inhibitor activity	negative regulation of hydrolase activity negative regulation of proteolysis regulation of catalytic activity negative regulation of biological process negative regulation of catalytic activity regulation of primary metabolic process negative regulation of peptidase activity organic substance metabolic process regulation of proteolysis proteolysis protein metabolic process negative regulation of protein metabolic process negative regulation of macromolecule metabolic process regulation of biological process negative regulation of hydrolase activity negative regulation of proteolysis regulation of catalytic activity negative regulation of biological process negative regulation of catalytic activity regulation of primary metabolic process negative regulation of peptidase activity organic substance metabolic process regulation of proteolysis proteolysis protein metabolic process negative regulation of protein metabolic process negative regulation of macromolecule metabolic process regulation of biological process organonitrogen compound metabolic process regulation of protein metabolic process negative regulation of metabolic process regulation of peptidase activity biological regulation negative regulation of molecular function primary metabolic process regulation of macromolecule metabolic process regulation of molecular function regulation of metallopeptidase activity regulation of hydrolase activity negative regulation of metallopeptidase activity metabolic process macromolecule metabolic process regulation of metabolic process negative regulation of membrane protein ectodomain proteolysis negative regulation of cellular catabolic process catabolic process regulation of cellular process macromolecule catabolic process negative regulation of cellular metabolic process negative regulation of protein catabolic process cellular catabolic process membrane protein proteolysis negative regulation of cellular process membrane protein ectodomain proteolysis organonitrogen compound catabolic process negative regulation of catabolic process regulation of membrane protein ectodomain proteolysis cellular metabolic process regulation of cellular metabolic process regulation of catabolic process protein catabolic process regulation of cellular catabolic process cellular process organic substance catabolic process regulation of protein catabolic process response to organic substance response to stimulus response to chemical response to cytokine response to hormone response to endogenous stimulus	membrane-bounded organelle intracellular anatomical structure tertiary granule lumen membrane-enclosed lumen intracellular vesicle cellular anatomical entity intracellular membrane-bounded organelle endomembrane system intracellular organelle lumen tertiary granule intracellular organelle organelle lumen cytoplasmic vesicle organelle membrane-bounded organelle intracellular anatomical structure tertiary granule lumen membrane-enclosed lumen intracellular vesicle cellular anatomical entity intracellular membrane-bounded organelle endomembrane system intracellular organelle lumen tertiary granule intracellular organelle organelle lumen cytoplasmic vesicle organelle secretory granule secretory vesicle cytoplasm vesicle extracellular region cell periphery extracellular matrix external encapsulating structure collagen-containing extracellular matrix vesicle lumen cytoplasmic vesicle lumen secretory granule lumen specific granule lumen specific granule extracellular space ficolin-1-rich granule ficolin-1-rich granule lumen

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A	IPR027465	Proteinase inhibitor I35b (TIMP), C-terminal	Homologous Superfamily
A	IPR001134	Netrin domain	Domain
A	IPR008993	Tissue inhibitor of metalloproteinases-like, OB-fold	Homologous Superfamily
A	IPR030490	Tissue inhibitor of metalloproteinase, conserved site	Conserved Site
A	IPR001820	Protease inhibitor I35 (TIMP)	Family

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A	Pharos: P16035	calcinosis extrahepatic cholestasis Occupational Diseases myocardial infarction pleural disease juvenile dermatomyositis lung cancer malignant glioma medulloblastoma myopathy atopic eczema pancreatic ductal adenocarcinoma Becker muscular dystrophy pilocytic astrocytoma primitive neuroectodermal tumor calcinosis extrahepatic cholestasis Occupational Diseases myocardial infarction pleural disease juvenile dermatomyositis lung cancer malignant glioma medulloblastoma myopathy atopic eczema pancreatic ductal adenocarcinoma Becker muscular dystrophy pilocytic astrocytoma primitive neuroectodermal tumor Duchenne muscular dystrophy ulcerative colitis glioblastoma limb-girdle muscular dystrophy lung carcinoma malignant mesothelioma atrial fibrillation pancreatic intraductal papillary-mucinous carcinoma pituitary cancer breast cancer Sjogren syndrome cancer subependymal giant cell astrocytoma Emery-Dreifuss muscular dystrophy facioscapulohumeral muscular dystrophy invasive ductal breast carcinoma malignant ependymoma malignant pancreatic neoplasm ovarian cancer atypical teratoid rhabdoid tumor pancreatic intraductal papillary-mucinous neoplasm with low grade dysplasia breast fibroadenoma eosinophilic esophagitis gastric carcinoma

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.